Legendary Brett Favre stands behind new concussion treatment

HATTIESBURG, MISS. – After years of studying the brain and looking at concussions, a doctor from Florida believes he made the discovery of a lifetime, and NFL Hall of Fame quarterback Brett Favre stands behind his new discovery. According to the Center for Disease Control (CDC), sports-related concussions have reached an epidemic level, with nearly 1.6 to 3.8 million happening each year in the United States. Due to the rising number of concussions, more people are starting to withdraw from contact sports. Youth football comes as one of the hardest sports impacted by concussion research with its participation numbers dropping by 19 percent. “There’s no solution, and concussions are going to happen,” Favre said. “I don’t care how much better the fields are, and I don’t care how much better the helmets become.” Over the years, the Hall of Fame quarterback made his stance very clear concerning youth tackle football. After 20 seasons in the NFL, Favre has been on the record saying he would not encourage his three grandchildren to play football. “I just cringe when I see it,” Favre said. “A part of me used to smile and say look at those kids, but now I cringed.” Currently, there is not a cure for concussions, but a neuroscientist from Florida, Jacob Vanlandingham believes he made the discovery of a lifetime. “We’re actually developing the first drug to treat concussions,” Dr. Vanlandingham said. “A solution that can be given on the sidelines immediately within ten minutes of the brain injury” Vanlandingham named his new discovery Prevacus and went on to elaborate about how quick the treatment would work, and instantly begin to affect a person’s brain. “Once that concussion is diagnosed the treatment, the is given immediately,” Dr. Vanlandingham said. “It’s given nasally, so it diffuses right into your brain. It’s in your brain in less than five minutes. It can diffuse in your brain in less than 30 minutes.” Ultimately, kicking fluids off of the brain and reducing swelling inside the skull significantly. Favre and Dr. Vanlandingham believe this discovery could make a positive impact in the world, and could potentially save lives. Recently, a high school football player in Georgia named Dylan Thomas passed away after suffering a concussion. Thomas suffered a concussion during the game, then sat out a couple of plays, but would later re-enter the game a second time. Thomas then took another hit and lost his life because of it.

“He had massive bleeding in his brain,” Dr. Vanlandingham said. “I believe if we had a drug something like Prevacus that we could have reduced some of the swelling on the sidelines, and he’d have a much better chance to survive.” Nearly, 300,000 high school athletes suffer a concussion each year, and Dr. Vanlandingham wants to make sure not another one loses their life participating in a sport they love. Prevacus will enter the first phase of human trials in January 2019 and could get picked up by the FDA in a couple years.

Visit www.Prevacus.com for more details about Prevacus.